Lipocine Inc.
LPCN
$3.03
$0.01410.47%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 622.80K | 93.90K | 3.49M | -- | 89.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 622.80K | 93.90K | 3.49M | -- | 89.60K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 622.80K | 93.90K | 3.49M | -- | 89.60K |
| SG&A Expenses | 890.40K | 1.12M | 873.10K | 1.05M | 1.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.03M | 2.18M | 1.95M | 2.63M | 3.38M |
| Operating Income | -2.40M | -2.09M | 1.55M | -2.63M | -3.29M |
| Income Before Tax | -2.21M | -1.86M | 1.78M | -2.22M | -3.07M |
| Income Tax Expenses | -- | 200.00 | 0.00 | -- | 500.00 |
| Earnings from Continuing Operations | -2.21M | -1.86M | 1.78M | -2.22M | -3.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.21M | -1.86M | 1.78M | -2.22M | -3.07M |
| EBIT | -2.40M | -2.09M | 1.55M | -2.63M | -3.29M |
| EBITDA | -2.39M | -2.07M | 1.56M | -2.62M | -3.28M |
| EPS Basic | -0.41 | -0.35 | 0.33 | -0.41 | -0.57 |
| Normalized Basic EPS | -0.26 | -0.22 | 0.21 | -0.26 | -0.36 |
| EPS Diluted | -0.41 | -0.35 | 0.31 | -0.44 | -0.57 |
| Normalized Diluted EPS | -0.26 | -0.22 | 0.20 | -0.26 | -0.36 |
| Average Basic Shares Outstanding | 5.35M | 5.35M | 5.35M | 5.35M | 5.34M |
| Average Diluted Shares Outstanding | 5.35M | 5.35M | 5.68M | 5.35M | 5.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |